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In this study, we examined the feasibility of membrane distillation (MD) for removing trace organic 
compounds (TrOCs) during water and wastewater treatment. A set of 29 compounds was selected to 
represent major TrOC groups, including pharmaceuticals, steroid hormones, phytoestrogens, UV-filters, 
industrial chemicals, and pesticides that occur ubiquitously in municipal wastewater. Results reported 
here suggest that rejection and fate and transport of TrOC during MD are governed by their volatility and, 
to a lesser extent, hydrophobicity. All TrOCs with pKH > 9 (which can be classified as non-volatile) were 
well removed by MD. Among the 29 TrOCs investigated in this study, three compounds (i.e. 
4-tertoctylphenol, 4-tert-butylphenol and benzophenone) possess moderate volatility (pKH < 9) and 
therefore had the lowest rejection efficiencies of 54, 73 and 66%, respectively. The results suggest that 
the rejection of TrOCs with pKH < 9 may be governed by the interplay between their hydrophobicity and 
volatility. In addition, the fate and transport of the TrOCs during the MD process was also investigated. 
Hydrophilic TrOCs having negligible volatility were concentrated in the feed, while hydrophobic 
compounds with moderate volatility were substantially lost due to evaporation or adsorption. When MD 
treatment was integrated with a thermophilic membrane bioreactor (MBR), near complete removal (> 
95%) of all 29 TrOCs investigated in this study was achieved despite their diverse physicochemical 
properties (i.e. hydrophobicity, persistency and volatility). The results suggest that MD could be a 
promising post-treatment to be used in conjunction with thermophilic MBR for TrOC removal. 
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Abstract 
In this study, we examined the feasibility of membrane distillation (MD) for removing 
trace organic compounds (TrOCs) during water and wastewater treatment. A set of 29 
compounds was selected to represent major TrOC groups, including pharmaceuticals, steroid 
hormones, phytoestrogens, UV-filters, industrial chemicals, and pesticides that occur 
ubiquitously in municipal wastewater. Results reported here suggest that rejection and fate and 
transport of TrOC during MD are governed by their volatility and, to a lesser extent, 
hydrophobicity. All TrOCs with pKH > 9 (which can be classified as non-volatile) were well 
removed by MD. Among the 29 TrOCs investigated in this study, three compounds (i.e. 4-tert-
octylphenol, 4-tert-butylphenol and benzophenone) possess moderate volatility (pKH < 9) and 
therefore had the lowest rejection efficiencies of 54, 73 and 66%, respectively. The results 
suggest that the rejection of TrOCs with pKH < 9 may be governed by the interplay between their 
hydrophobicity and volatility. In addition, the fate and transport of the TrOCs during the MD 
process was also investigated. Hydrophilic TrOCs having negligible volatility were concentrated 
in the feed, while hydrophobic compounds with moderate volatility were substantially lost due to 
evaporation or adsorption. When MD treatment was integrated with a thermophilic membrane 
bioreactor (MBR), near complete removal (> 95%) of all 29 TrOCs investigated in this study was 
achieved despite their diverse physicochemical properties (i.e. hydrophobicity, persistency and 
volatility). The results suggest that MD could be a promising post-treatment to be used in 
conjunction with thermophilic MBR for TrOC removal. 
Keywords: Trace organic compounds (TrOCs), direct contact membrane distillation (DCMD), 
volatility, fate and transport, hydrophobicity/hydrophilicity.  
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1. Introduction  
Membrane distillation (MD) is a low temperature distillation process that involves the 
transport of water in the vapour phase from a feed solution through a microporous and 
hydrophobic membrane to the distillate (product) side. Direct contact membrane distillation 
(DCMD) is probably the most widely studied MD system configuration due to its simple 
operation [1-2]. In DCMD, the feed solution is maintained at a higher temperature than the 
distillate; thus, creating a vapour pressure difference between the feed and distillate. The 
membrane separates the liquid phase of the feed and distillate streams but allows water vapour to 
transport freely through its dry micro porous pores. In MD, the membrane material must be 
hydrophobic to prevent flooding of the pores by liquid feed or distillate under standard operating 
conditions. Because mass transfer can occur only in the gas phase, MD can offer complete 
rejection of all non-volatile solutes such as inorganic salts and pathogenic agents. As a result, to 
date, much of the effort in MD research has focused on desalination applications [2-5].  
Unlike pressure driven membrane processes, due to the absence of a hydraulic pressure, 
MD is less susceptible to membrane fouling [3, 6]. Even when membrane fouling does occur, it 
is expected to be a less compacted layer and can be easily removed [3, 7-8]. The low operating 
temperature of MD allows for the utilization of solar thermal or low grade heat as the energy 
source [1-2, 9-13]. Given the advantages of high separation efficiency, low fouling propensity, 
and potentially low energy consumption (when low grade heat is readily available), MD can be 
useful for a range of applications beyond those for brackish and seawater desalination. Several 
studies have explored the use of MD for food processing, such as whey protein recovery in dairy 
processing [8], polyphenolic antioxidants from olive oil wastewater [14], and orange juice 
concentration [15], separation of fermentation broth [16] as well as treatment of wastewater from 
the textile [17] and petrochemical industries [10], and municipal water reuse [11, 18]. 
Despite the growing interest in using MD for treatment of a range of wastewaters, there is 
still a lack of understanding of the rejection mechanisms of trace organic compounds (TrOCs) by 
MD. These TrOCs have been frequently detected in raw sewage and biologically treated effluent 
at concentrations ranging from several ng/L to several µg/L [19-23]. As a result, the removal of 
these TrOCs from secondary treated effluent by advanced treatment processes such as 
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nanofiltration (NF), reverse osmosis (RO), oxidation and activated carbon adsorption has been 
extensively investigated in recent years [24-28]. Nevertheless, only a few studies have been 
conducted to elucidate the rejection of specific organic compounds by MD. Moreover, the 
available studies are mostly concerned with industrial chemicals such as benzene [29] and 
trichloroethylene [30] at an elevated feed concentration. 
Given the concerns associated with human and environmental exposure to TrOCs, it is 
important to elucidate their fate and transport during MD, particularly in water reuse 
applications. Examples of these include the investigation by Cath et al. [18] and Cartinella et al. 
[31] to treat urine and hygiene wastewater by MD for water reuse in long term space missions 
and the novel membrane distillation membrane bioreactor (MDBR) concept proposed by 
Phattaranawik et al. [11] and Goh et al. [32]. 
In this paper, we studied the rejection of a broad range of TrOCs by MD. The potential 
application of MD as a post treatment for thermophilic MBR to enhance TrOC removal was also 
investigated. The transport and fate of TrOCs during MD treatment are discussed with respect to 
compound hydrophobicity and volatility (measured by the log D and the Henry’s law constant, 
respectively). The results provide further insight with respect to TrOC rejection using MD, 
which is critical for the further development of this technology for wastewater reclamation 
applications. 
2. Materials and Methods 
2.1. Experimental system  
The rejection of TrOCs by MD was evaluated using a hydrophobic microporous 
polytetrafloroethylene (PTFE) membrane (GE, Minnetonka, MN) and a laboratory-scale DCMD 
system [33]. According to the manufacturer, the average pore size and porosity of the MD 
membrane were 0.22 µm and 70%, respectively. The DCMD system (Fig. 1) comprised a 
membrane cell, a stainless steel feed tank, a glass distillate tank, two circulation pumps 
(Micropump Inc., USA), a temperature controller (Coleparmer, USA), and a heating element 
(Process Technology, USA). The membrane cell was made of acrylic glass, and a flow channel 
was engraved in each of the two acrylic glass blocks that make up the feed and permeate semi-
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cells. The length, width, and height of each channel were 145, 95, and 3 mm, respectively. The 
feed solution was circulated from a stainless steel reservoir to the membrane cell and then 
returned back to the feed reservoir. A temperature sensor was placed immediately before the feed 
inlet to the membrane cell. The heating element and the temperature sensor were connected to a 
temperature control unit that was used to regulate the temperature of the feed solution. Another 
temperature sensor was installed immediately at the outlet of the distillate semi-cell. The 
temperature of the distillate was regulated using a chiller (AquaCooler, Australia) equipped with 
a stainless steel heat exchanging coil immersed directly in the distillate reservoir. Excess water 
was allowed to overflow from the distillate reservoir into a glass container, placed and 
continuously weighed on an analytical balance (Mettler Toledo, Switzerland). All pipework used 
in the DCMD test unit was covered with insulation foam to minimize heat loss. The feed and 
distillate tanks were covered with aluminium foil to minimise evaporation loss during the 
experiment. At the end of each experiment, the solution volume was measured again and the 
total volume loss was found to be less than 6%. 
[FIGURE 1]  
One set of MD experiments was conducted using a synthetic feed solution containing 
approximately 5 µg/L of each TrOC in Milli-Q water. In another set of experiments, effluent 
obtained from a thermophilic MBR system (Supplementary Data Fig. S1) was used as the feed 
solution to evaluate the feasibility of combining MD with MBR. The MBR and MD experiments 
were conducted separately.  The MBR system consisted of a 5 L glass reactor immersed in a PID 
control water bath (Julabo, Germany), three peristaltic pumps (Masterflex L/S, USA) for feeding, 
recirculation and effluent extraction, and an external ceramic membrane module (NGK, Japan). 
The ceramic membrane had a nominal pore size of 1 μm and effective area of 0.09 m2. Further 
details of this MBR system are available elsewhere [34]. 
2.2. Experimental protocol  
In all MD experiments, the feed and distillate temperatures were 40 and 20 °C, 
respectively and the cross flow velocity of the feed and distillate circulation flow was 11.7 cm/s. 
The initial feed volume was 10 L. The experiment was concluded once the water recovery had 
reached 70% at which stage the feed and distillate samples were collected for TrOC analysis. 
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The duration of each MD experiment was approximately 24 h. At the beginning of each MD 
experiment, 3.35 L of Milli-Q water was used as the initial distillate. Thus, TrOC concentration 
in the distillate was corrected for dilution by taking into account the initial volume of Milli-Q 
water in the distillate.  
The MBR system was operated under thermophilic conditions (40 °C) with an average 
dissolved oxygen (DO) concentration of 2.9 mg/L, hydraulic retention time of 24 hr, and average 
mixed liquor pH of 7.7. Excess sludge was withdrawn every week to maintain the mixed liquor 
suspended solid (MLSS) concentration in the reactor at 5000 mg/L, resulting in a solids retention 
time (SRT) of 140 days. The system was fed with a synthetic wastewater containing 100 mg/L 
glucose, 100 mg/L  peptone, 17.5 mg/L KH2PO4, 17.5 mg/L MgSO4, 10 mg/L FeSO4, 225 mg/L 
CH3COONa and 35 mg/L urea [35].  
Prior to the commencement of this study, the MBR system had been acclimatized at 40 
°C and operated for more than two months to produce constant effluent quality (Supplementary 
Data Fig. S2). TrOCs were introduced to the MBR feed to obtain approximately 5 µg/L of each 
compound and the MBR system was operated continuously at similar operating conditions. 
Then, the effluent was collected and used as MD feed. In good agreement with the previous 
studies [24, 36-37] no significant difference in the biological performances of the MBR was 
observed following the introduction of TrOC. Key operational parameters including MLSS, 
mixed liquor volatile suspended solid (MLVSS), DO, TOC and TN removal, and permeate 
turbidity were continuously monitored to ensure the biological stability of the MBR. The 
performance of the MBR system was stable throughout this study with respect to these 
parameters. TOC and TN removal were stable at 91 and 47%, respectively. The turbidity of the 
MBR permeate was always below 0.9 NTU. The MLVSS/MLSS ratio of the sludge remained 
constant at approximately 0.76 throughout the experimental period. In addition, the MBR system 
was operated at a transmembrane pressure (TMP) below 90 kPa (13 psig) to maintain a constant 
permeate flux, and no abnormal variation in TMP was observed over the entire study 
(Supplementary Data Fig. S3). 







P        (1) 
where Cp and CF are concentration of the specific compound in the permeate and feed, 
respectively. The term rejection was used for the MD process while the term removal was used 
for MBR and the combined treatment of MBR and MD to take into account the fact that TrOC 
can also be biologically degraded. Losses of TrOCs during the MD process were calculated by 
considering the mass balance of each compound in the feed, concentrate and distillate as given in 
Equation 2.  
    losstotalVCVCVC CCDDFF                   (2) 
In Equation 2, CF, CD and CC are concentration in the feed, distillate and concentrate, 
respectively. Similarly, VF, VD and VC are the volume of the feed, distillate and concentrate, 
respectively. 
2.3.  Trace organic contaminants 
A set of 29 TrOCs was selected to represent pharmaceuticals, steroid hormones, 
phytoestrogens, UV-filters (i.e., active ingredients of sunscreens), industrial chemicals, and 
pesticides that occur ubiquitously in municipal wastewater [19-23]. Analytical grade samples of 
these compounds were obtained from Sigma-Aldrich (Saint Louis, MO, USA). A combined 
stock solution of all the TrOCs was prepared in pure methanol and kept at -18 ºC in the dark. 
Log D values of these compounds were obtained from the SciFinder Scholar database 
(https://scifinder.cas.org/scifinder) at pH 9 (Table 1). Vapour pressure, molecular weight (MW), 
and water solubility of each selected compound were also obtained from the SciFinder Scholar 
database (Supplementary Data Table S1) to calculate the Henry’s law constant as: H 
(atm.m3/mol) = Vapour pressure×MW/water solubility. The pKH value presented in Table 1 is 
defined as pKH = -log10H. It is important to note that because the water solubility used to 
calculate the Henry’s law constant was obtained at 25 ºC, the actual pKH values at 40 ºC (which 
was used during the MD experiment) could deviate slightly from those values presented in the 
Table 1.  
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The pH of the synthetic feed solution was 8.5 and 8.6 at the beginning and the end of the 
MD experiment, respectively. The initial pH value of the MBR effluent was 7.8 and it increased 
to pH 9.1 by the end of the experiment. Accordingly, the log D and pKH values of the TrOCs 
investigated in this study were obtained at pH 9 (Table 1). 
[TABLE 1] 
2.4.  Analytical methods 
2.4.1 Basic water quality parameters 
Total organic carbon (TOC) and total nitrogen (TN) were analysed using a Shimadzu 
TOC/TN-VCSH analyser (Shimadzu, Kyoto, Japan). TOC analysis was conducted in non-
purgeable organic carbon mode. Electrical conductivity and pH of the feed and distillate were 
monitored using an Orion 4 Star Plus portable pH/conductivity meter (Thermo Scientific, 
Waltham, MA).  
2.4.2   TrOC analysis  
TrOC concentrations were determined using an analytical method previously reported by 
Hai et al. [38]. This method consisted of a solid phase extraction procedure followed by gas 
chromatography separation and quantitative determination using a mass spectrometry detector 
with electron ionization. Feed and distillate samples (500 mL each) were extracted using 6 mL 
200 mg Oasis HLB cartridge (Waters, Milford, MA, USA). First, the cartridges were 
preconditioned with 7 mL dichloromethane and methanol mixture (1:1 v/v), 7 mL methanol, and 
7 mL reagent water (Milli-Q water). The samples were acidified to pH 2-3 and loaded onto the 
cartridges at a flow rate of 1-5 mL/min. The cartridges were then rinsed with 20 mL Milli-Q 
water and dried in a stream of nitrogen for 30 min. The extracted TrOCs were eluted from the 
cartridge using 7 mL of methanol followed by dichloromethane and methanol mixture (1:1 v/v) 
at a flow rate of 1-5 mL/min. The eluents were subsequently evaporated using a water bath (40 
°C) under a gentle stream of nitrogen. The extracts were dissolved with 200 µL methanol which 
contained 5 µg bisphenol A-d16 and transferred into 1.5 mL vials, and then further evaporated 
under a gentle stream of nitrogen. Finally, the extracts were derivatized by adding 100 µL of  
N,O-Bis(trimethylsilyl)trifluoroacetamide (1% trimethylchlorosilane) and pyridine (dried with 
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KOH solid), then heated in a heating block (60–70 °C) for 30 min. The derivatives were cooled 
to room temperature and analysed using a Shimadzu QP5000 GC–MS (Shimadzu, Kyoto, Japan) 
equipped with a AOC20i autosampler and a Phenomenex Zebron ZB-5 (5% diphenyl–95% 
dimethylpolysiloxane) capillary column (30 m × 0.25 mm ID, df  = 0.25 µm). The detection limit 
of the selected compounds was in the range of 1 to 20 ng/L [38]. 
3. Results and discussion 
3.1    Basic Performance of the MD Process 
The MD experiments were analyzed considering the distillate flux, water recovery, pH 
and conductivity variation (Supplementary Data Table S1). The distillate flux was continuously 
monitored to assess the stability (Fig. 2). There was no notable difference in the performance of 
the MD process with respect to the water flux and conductivity rejection when either the 
synthetic solution or MBR effluent was used as the feed. Both experiments achieved satisfactory 
water recovery at 70%. The average TOC and TN concentrations of the MBR effluent were 15 ± 
6 and 17 ± 4 mg/L, respectively. However, this high residual organic content in the MBR 
effluent did not exert any negative impact on the MD process. TOC and TN concentrations of the 
distillate were consistently less than 1 mg/L. When either the synthetic solution or the MBR 
effluent was used as the feed to the MD process, the water flux was stable at approximately 17.5 
L/m2.h and no flux decline was observed during the entire experimental period (Fig. 2). The 
conductivity of the distillate was consistently below 10 µS/cm regardless of the salinity level in 
the feed (Supplementary Data Table S1). 
[FIGURE 2] 
3.2   Rejection and fate of TrOCs during MD    
3.2.1   TrOC rejection  
Most of the 29 TrOCs investigated were effectively removed by MD (Fig. 3). However, it 
is important to note that only a moderate rejection efficiency was observed for several 
compounds. In particular, 4-tert-octylphenol showed the lowest rejection (54%). In MD, mass 
transfer occurs only in the gas (vapour) phase. Thus, the transport of TrOCs from the feed to the 
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distillate solution depends on their volatility. Not surprisingly, all TrOCs with pKH value higher 
than 9 (low volatility) were well removed by the MD process. Oxybenzone is the only exception. 
Compared to other TrOCs, the relatively lower rejection (81%) of oxybenzone in relation to its 
pKH value as plotted in Fig. 3 could be attributed to the strong dependence of its pKH value on 
pH. pKH values at pH 9 have been plotted in Fig. 3. However, it is noteworthy that the pKH value 
of oxybenzone changes from 9.23 to 8.39 when the solution pH decreases from 9 to 8 
(Supplementary Data Table S2). Because in this study the feed solution pH was 8.5 and 8.6 at the 
beginning and the end of the MD experiment, respectively, the interpolated pKH (8.6) value of 
oxybenzone is actually below 9. The three TrOCs with the lowest rejection (i.e., 4-tert-
octylphenol, 4-tert-butylphenol and benzophenone) also have the highest volatility (or lowest 
pKH values) amongst the 29 TrOCs studied. Low rejection of volatile organic compounds such 
as benzene [29] and trichloroethylene [30] by MD have been previously reported in the 
literature. However, in this study, there was no obvious correlation between rejection efficiencies 
and pKH values for TrOCs possessing a pKH value of less than 9. The data presented in Fig. 3 
suggest that in addition to volatility, other physicochemical properties such as hydrophobicity 
(which can be obtained from log D) may also influence the transport of TrOCs during MD. In 
fact, octocrylene, which has the fourth lowest rejection value of 81%, is also the most 
hydrophobic compound of the 29 TrOCs. In addition, in this study most of the TrOCs with pKH 
of less than 9 were also hydrophobic (i.e., log D>3) and their rejection efficiency varied widely 
from as low as 54% (i.e., 4-tert-octylphenol) to near complete rejection. Significant adsorption of 
hydrophobic organics to the MD membrane has been previously reported by Zuo and Wang [39]. 
The results reported in Fig. 3 suggest that the rejection of TrOCs may be governed by the 
interplay between their volatility and hydrophobicity. 
 [FIGURE 3] 
3.2.2  Fate of TrOCs in the MD process  
The fate of TrOCs during the MD experiments is presented in Fig. 4. Considering each 
experiment as a closed system, any loss of TrOCs could be attributed to either evaporation or 
adsorption to the membrane. The former is governed by the volatility and the latter is governed 
by the hydrophobicity. Both of these physicochemical properties could be important in 
determining the fate of TrOCs during MD (Fig. 4). Results reported in this study reveal that the 
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hydrophilic TrOCs with low volatility (pKH>9) can be concentrated in the feed. On the other 
hand, significant losses through either evaporation or adsorption could be observed for 
moderately volatile (i.e. pKH value < 9) and hydrophobic (i.e. log D > 3) compounds. As a result, 
moderately volatile and hydrophobic compounds such as triclosan, propoxur, amitryptyline, 
octocrylene and 17β–estradiol-17-acetate did not accumulate in the feed. Indeed, concentrations 
of all three compounds (i.e. 4-tert-octylphenol, 4-tert-butylphenol and benzophenone) with the 
lowest pKH in the concentrate at the end of the experiment were lower than the initial values 
(Supplementary Data, Table S3). In addition, the rejections of these compounds by MD were 
also the lowest amongst the 29 TrOCs investigated here (Fig. 4).  
[FIGURE 4] 
3.3  MBR-MD system  
MD can be operated with feed temperature compatible to that in thermophilic MBR, these two 
processes can complement each other for an enhanced performance. TrOC concentrations in the 
feed and after each of these treatment steps are shown in Supplementary Data Table S4. MBR 
treatment effectively removed most of the 29 TrOCs investigated in this study. High removal of 
these compounds during MBR treatment has also been reported elsewhere [25, 36-37, 40]. 
However, several compounds including propoxur, atrazine, ametryn, clofibric acid, diclofenac, 
carbamazepine, naproxen and fenoprop were found to be persistent to MBR treatment, and their 
residual concentrations in the MBR effluent were relatively high. Low removal efficiencies of 
these compounds have also been reported in several previous studies [36, 41-42]. It is noted that 
the removal efficiency of these compounds under thermophilic conditions in this study were 
comparatively lower than that observed in our previous study under mesophilic conditions [37]. 
The low removal of most of the persistent compounds can be attributed to the disturbed 
metabolic activity generally associated with the biological treatment at elevated temperatures 
[38]. Nevertheless, as illustrated in Fig.5, all TrOCs including those that were resistant to MBR 
treatment were effectively removed by the MD process. In this study, complete or near complete 
(> 95%) removal efficiency of all 29 TrOCs was achieved by the combined MBR-MD treatment.  
TrOC removal by MD as a post treatment step following an MBR has not been reported in the 
literature. On the other hand, the use of other post treatment processes such as NF and RO 
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desalination subsequent to MBR has been previously demonstrated [24-25, 43-44]. Tam et al. 
[43] reported near complete removal of estrogens and disinfection by-products (trihalomethanes 
and halo-acetic acids) by a pilot MBR/RO system. Alturki et al. [24] also demonstrated the 
benefits of coupling MBR treatment and NF/RO desalination for removing 40 TrOCs with a 
diverse range of physicochemical properties. Results reported in the current study suggest that an 
MBR-MD hybrid system could be as effective as an MBR-NF/RO system for removing TrOCs. 
In addition, high removal of TrOCs by a combination of MBR and MD treatment can be 
achieved regardless of the diversity of their volatility, persistency, and hydrophobicity.  
The results shed light on the prospective of integrating MD with MBR for TrOC removal (e.g., 
MBR coupled MD (multi pass) system and MD bioreactor), and the salinity affected 
complexities on removal performance would be vital to investigate. However, it was not within 
the scope of the current study. Overall, the high water flux, excellent distillate quality and the 
near complete removal of TrOCs reported here suggests that MBR-MD system could be used to 
ensure safe water reuse.  
 [FIGURE 5] 
4. Conclusion 
In this study, we have investigated the rejection of 29 trace organic compounds (TrOCs) 
and their fate in a membrane distillation (MD) system. Results reported here suggest that 
rejection and fate and transport of TrOC during MD would be mainly governed by the volatility 
and partially governed by the hydrophobicity of the compound. All TrOCs with pKH > 9 (which 
can be classified as non-volatile) were highly removed by MD. However, three compounds (i.e., 
4-tert-octylphenol, 4-tert-butylphenol and benzophenone) with pKH < 9 and thus classified as 
partially volatile showed relatively low rejection efficiencies (i.e., 54, 73 and 66%, respectively). 
The results also suggest that the rejection of TrOCs with pKH < 9 may be governed by the 
interplay between their hydrophobicity and volatility. In addition, the reported results show that 
hydrophilic TrOCs having negligible volatility were concentrated in the feed, while hydrophobic 
compounds with moderate volatility were substantially lost due to evaporation or adsorption to 
membrane. Membrane bioreactor followed by MD treatment resulted in near complete (> 95%) 
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removal of all 29 TrOCs despite their diverse physicochemical properties (i.e., hydrophobicity, 
persistency and volatility). 
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Table S1: MD and MBR-MD experimental conditions. 
Parameter Phase 
 MD Experiment 
with Milli-Q as feed 
MD experiment with 
MBR permeate as feed 
pH 
MD feed 8.5 7.8 
MD concentrate 8.6  9.1  
Initial distillate 7.3  7.3  
Final distillate 7.7  9.6  
Conductivity 
(µS/cm) 
MD feed 18 ± 0.3 322 ± 2.0 
MD concentrate 130 ± 17 1026 ± 46 
Initial distillate 1.1 ± 0.1 1.3 ± 0.2 
Final distillate 6.9 ± 0.4 9.3 ±0.1 
Note: 1.Volume loss due to evaporation remained less than 1 L in each test.  




Table S2: pKH of oxybenzone at different pH values. 
pH   Log D 
Water Solubility at 
25oC and pH 8 (mg/L)
Vapour Pressure 
at 25oC  (mmHg) 
pKH 
pH 8 3.42 390 5.26 ×10-6 8.39





































Note: Error represents the standard deviation from four measurements (duplicate samples from two replicate experiments). MD was carried out at the feed and 





Log D at 
pH 9 
Feed (ng/L) Concentrate (ng/L) Distillate (ng/L) 
Mean  Error (±) Mean Error (±) Mean Error (±) 
4-tert-Octylphenol 5.06 5.18 2292 828 585 110 631 109 
4-tert-Butylphenol 5.15 3.37 1881 0 350 147 245 58 
Benzophenone 5.88 3.21 666 0 274 26 128 44 
Triclosan 6.19 4.12 3470 242 1019 232 115 26 
Propoxur 6.28 1.54 1653 261 81 92 7 5 
Atrazine 7.28 2.64 2462 89 10722 387 57 16 
Pentachlorophenol 7.59 1.99 2924 459 8223 253 53 17 
Amitriptyline 8.18 4.01 2465 455 1569 105 217 84 
Ametryn 8.43 2.97 3133 117 10643 420 100 31 
Octocrylene 8.47 6.89 888 229 371 76 95 49 
Bisphenol A 8.66 3.62 3077 60 9070 266 283 56 
17 β – Estrodiol- 17- acetate 8.67 5.11 3097 202 1192 278 76 62 
17 β – Estradiol 8.93 4.12 3557 20 6944 603 38 24 
Estrone 9.03 3.6 4163 34 9231 271 140 79 
Carbamazapine 9.09 1.89 1806 105 6053 463 57 20 
Oxybenzone 9.23 2.55 3531 333 2877 519 638 41 
17 α – Ethinylestradiol 9.43 4.08 3276 145 4468 389 55 28 
Clofibric acid 9.54 -1.32 3539 115 11594 72 22 14 
Ibuprofen 10.39 -0.19 3555 288 13669 50 12 12 
Estriol 10.80 2.5 3124 389 6866 1172 16 16 
Fenoprop 11.48 -0.29 2330 42 7873 272 63 45 
Diclofenac 11.51 0.83 3527 168 11633 414 123 132 
Metronidazole 11.68 -0.14 742 156 3448 486 103 146 
Gemifibrozil 12.11 0.67 3941 82 13514 191 34 16 
Naproxen 12.68 -0.73 3794 199 13581 500 6 3 
Formononetin 13.22 0.88 1432 297 5534 285 7 1 
Ketoprofen 13.70 -0.84 3268 141 11493 180 24 2 
Primidone 13.93 0.83 1698 121 7280 88 5 4 








































Log D at 
pH 9 
MBR feed (ng/L) 
MBR Permeate (MD 
feed)  (ng/L) 
MD Concentrate  
(ng/L) 
Distillate  (ng/L) 
Mean Error (±) Mean Error (±) Mean Error (±) Mean Error (±) 
4-tert-Octylphenol 5.06 5.18 4683 9 147 11 278 69 96 65 
4-tert-Butylphenol 5.15 3.37 4240 45 112 19 116 30 51 23 
Benzophenone 5.88 3.21 1568 166 205 35 78 25 37 41 
Triclosan 6.19 4.12 4496 29 114 17 155 17 26 1 
Propoxur 6.28 1.54 4445 68 3011 278 164 53 39 14 
Atrazine 7.28 2.64 2800 107 3215 98 10034 1142 28 10 
Pentachlorophenol 7.59 1.99 4588 150 441 70 1039 254 13 16 
Amitriptyline 8.18 4.01 4143 484 149 42 40 3 36 30 
Ametryn 8.43 2.97 4032 24 1655 121 4639 410 25 6 
Octocrylene 8.47 6.89 1231 235 31 21 50 18 33 14 
Bisphenol A 8.66 3.62 4919 854 56 1 756 17 178 13 
17 β – Estrodiol- 17- acetate 8.67 5.11 3956 45 12 6 27 27 27 20 
17 β – Estradiol 8.93 4.12 4359 22 5 5 0 0 0 0 
Estrone 9.03 3.6 4654 26 31 2 40 5 21 17 
Carbamazapine 9.09 1.89 3332 142 2093 93 8022 1332 32 12 
Oxybenzone 9.23 2.55 5043 8 56 4 31 31 8 5 
17 α – Ethinylestradiol 9.43 4.08 4131 339 236 22 125 91 80 11 
Clofibric acid 9.54 -1.32 4230 63 2448 156 7245 1092 7 2 
Ibuprofen 10.39 -0.19 4915 191 57 16 131 24 5 6 
Estriol 10.8 2.5 3680 387 88 22 22 22 16 17 
Fenoprop 11.48 -0.29 3940 202 2071 108 5203 600 25 18 
Diclofenac 11.51 0.83 3258 39 3916 49 9993 645 19 5 
Metronidazole 11.68 -0.14 851 86 127 2 282 86 5 5 
Gemifibrozil 12.11 0.67 4628 17 456 29 1473 183 6 1 
Naproxen 12.68 -0.73 4746 196 2292 133 6749 296 2 2 
Formononetin 13.22 0.88 1081 727 35 10 61 34 27 4 
Ketoprofen 13.7 -0.84 4452 107 273 29 757 41 23 6 
Primidone 13.93 0.83 2627 181 14 4 82 41 2 2 












































   to 40oC
Stable Operation 













































Figure S2: Variation of TOC and TN removal of MBR during acclimatization to 
thermophilic condition (40 °C) and stable operation at 40 °C. Operated HRT, permeate flux, 
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Figure S3: TMP profile of the MBR during acclimatization to thermophilic condition (40 °C) 
and stable operation at 40 °C. HRT and permeate flux were 24 h and 2.36 L/m2.h (equivalent 
to 5 L/d), respectively. 
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LIST OF FIGURE CAPTIONS 1 
Figure 1: Schematic diagram of the DCMD system. 2 
Figure 2: Permeate flux variation of MD and MBR–MD experiments: MD was carried out at 3 
feed and distillate temperatures of 40 and 20 °C, respectively; and feed and distillate 4 
circulation flow rate of 2 L/min (corresponding to 11.7 cm/s).  5 
Figure 3: Rejection of the 29 TrOCs by DCMD and their log D and pKH values. Log D and 6 
pKH illustrate the values at the pH 9. Error bars represent the standard deviation from four 7 
replicate measurements. Synthetic solution containing approximately 5 µg/L of each TrOC in 8 
Milli-Q water was used as the feed. The MD was carried out at the feed and distillate 9 
temperatures of 40 and 20 °C, respectively. The feed and distillate circulation flow rate was 2 10 
L/min (corresponding to 11.7 cm/s).  11 
Figure 4: The fate of the 29 TrOCs in the DCMD process with their log D and pKH values. 12 
Log D and pKH illustrate the values at the pH 9. Synthetic solution containing approximately 13 
5 µg/L of each TrOC in Milli-Q water was used as the feed. The fate of each compound was 14 
analyzed by mass balance considering the total input, mass in concentrate and permeate, and 15 
loss due to evaporation or adsorption. Calculation of the fate of TrOCs during the MD 16 
process was based on the average value of four measurements (duplicate samples from two 17 
replicate experiments).  18 
Figure 5: Removal of TrOCs by the thermophilic MBR and by the MBR-MD as well as their 19 
log D and pKH values. Log D and pKH illustrate the values at the pH 9. MBR permeate was 20 
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(b) MBR-MD experiment 
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Log D at 
pH 9 






Enterolactone C18H18O4 298.33 1.89 200 3.29 ×10
-13 15.19 
Primidone C12H14N2O2 218.25 0.83 1,500 6.08 ×10
-11 13.93 
Ketoprofen C16H14O3 254.30 -0.84 554,000 3.32×10
-8 13.70 
Formononetin C16H12O4 268.26 0.88 4800 8.17 ×10
-10 13.22 
Naproxen C14H14O3 230.30 -0.73 435,000 3.01×10
-7 12.68 
Gemfibrozil C15H22O3 250.30 0.67 263,000 6.13×10
-7 12.11 
Metronidazole C6H9N3O3 171.15 -0.14 29,000 2.67×10
-7 11.68 
Diclofenac C14H11Cl2NO2 296.15 0.83 20,000 1.59×10
-7 11.51 
Fenoprop C9H7Cl3O3 269.51 -0.29 230,000 2.13×10
-6 11.48 
Estriol  C18H24O3 288.40 2.5 32 1.34 ×10
-9 10.80 
Ibuprofen C13H18O2 206.30 -0.19 928,000 1.39 ×10
-4 10.39 
Clofibric acid C10H11ClO3 214.64 -1.32 100,000 1.03 ×10
-4 9.54 
17 α – Ethinylestradiol  C20H24O2 296.48 4.08 3.9 3.74 ×10
-9 9.43 
Oxybenzone C14H12O3 228.24 2.55 2700 5.26 ×10
-6 9.23 
Carbamazepine C15H12N2O 236.27 1.89 220 5.78×10
-7 9.09 
Estrone  C18H22O2 270.36 3.6 5.9 1.54 ×10
-8 9.03 
17 β – Estradiol  C18H24O2 272.38 4.12 3 9.82 ×10
-9 8.93 
17 β – Estrodiol- 17- acetate C20H26O3 314.42 5.11 1.9 9.88 ×10
-9 8.67 
Bisphenol A C15H16O2 228.29 3.62 73 5.34 ×10
-7 8.66 
Octocrylene C24H27N 361.48 6.89 0.36 2.56 ×10
-9 8.47 
Ametryn C9H17N5S 227.33 2.97 140 1.72 ×10
-6 8.43 
Amitriptyline C20H23N 277.40 4.01 83 1.50 ×10
-6 8.18 
Pentachlorophenol C6HCl5O 266.38 1.99 4800 3.49×10
-4 7.59 
Atrazine C8H14ClN5 215.68 2.64 69 1.27 ×10
-5 7.28 
Propoxur C11H15NO3 209.24 1.54 800 1.53 ×10
-3 6.28 
Triclosan C12H7Cl3O2 289.54 4.12 19 3.26×10
-5 6.18 
Benzophenone C13H10O 182.22 3.21 150 8.23 ×10
-4 5.88 
4-tert-butyphenol C10H14O 150.22 3.37 1000 0.0361 5.15 
4-tert-octylphenol C14H22O 206.33 5.18 62 1.98 ×10
-3 5.06 
 3 
